Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Bad
|
New words:
assignment, cashflow, composed, consecutive, consummating, cumulative, demanded, Dr, EDIL, employment, forward, longevity, merged, partial, Portala, repayment, risen, room, RxCompoundand, soft, Suite, SW, Tadalfil, upgrading, VCMAJI, virtue
Removed:
accruing, ads, Agency, arisen, attempting, began, certified, corporate, create, DEA, default, determining, develop, doctor, Drug, dysfunction, Enforcement, enhanced, erectile, expand, fill, flagship, formulation, HCG, high, ideal, implemented, injected, innovative, issuable, licensed, licensure, main, medication, meet, monthly, nutraceutical, path, patient, prepare, prescription, priority, produce, quality, ready, referring, registered, Regulation, respond, safely, seek, seeking, sell, send, settled, testosterone, thereunder, treating, TriMix, unique, York
Valuein 2023 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view